Mer­ck­'s Keytru­da-chemo re­duces risk of death from bil­iary tract can­cer by 17%: #AACR23

OR­LAN­DO — Mer­ck’s Keytru­da racked up an­oth­er po­ten­tial win on Sun­day, show­ing pos­i­tive re­sults as a first-line treat­ment for ad­vanced bil­iary tract can­cers, for which …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER